1、序号:1 题名:Pharmacodynamicsand pharmacokinetics of the HMG-CoA reductaseinhibitors.Similarities and differences 作者:H. Lennernas,G. Fager. 期刊: Clin.Pharmacokinet,
页码:1997, 32:403-425.
链接:无 2、序号:2 题名:HPLC Determinationof Lovastatin in Rat Tissue 作者:Z.F.Zhang,Z.Y.Yang. 期刊:Chromatography2007, 66(7-8)
页码:487-491.
链接:无 3、序号:3 题名:Expandedclinical evaluation of lovastain(EXCEL)study results:efficacy in modifying plasma lipoproteins and adverse event profile in8245 patients with moderate hypercholesterolemia 作者:R.H.Bradford, C.L. Shear, A.N. Chremos et al. 期刊: Arch.Intern.Med.,1991, 151 页码:43-49.
链接:无
4、序号:4 题名:Mevinolin:a highly potent competitive inhibitor ofhydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. 作者:A.W.Alberts,J. Chen, G. Kuron. 期刊:Proceedingsof the National Academy of Sciences of the United States of America, 1980, 77(7) 页码:3957-3961. 链接:无